Kathryn C. Zoon - 12 Mar 2025 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
12 Mar 2025
Net transactions value
-$57,300
Form type
4
Filing time
12 Mar 2025, 18:13:08 UTC
Previous filing
06 Jun 2024
Next filing
02 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale $57,300 -10,000 -18% $5.73 44,482 12 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.